Gonorrhea Lecture
Gonorrhea Lecture
Gonorrhea Lecture
Gonorrhea
Neisseria gonorrhoeae
1
Gonorrhea Curriculum
Learning Objectives
Upon completion of this content, the learner will be able to:
1. Describe the epidemiology of gonorrhea in the U.S.
2. Describe the pathogenesis of Neisseria gonorrhoeae.
3. Discuss the clinical manifestations of gonorrhea.
4. Identify common methods used in the diagnosis of gonorrhea.
5. List CDC-recommended treatment regimens for gonorrhea.
6. Summarize appropriate prevention counseling messages for
patients with gonorrhea.
7. Describe public health measures for the prevention of
gonorrhea.
2
Gonorrhea Curriculum Epidemiology
3
Gonorrhea Curriculum Epidemiology
Risk Factors
• Multiple or new sex partners or inconsistent
condom use
• Urban residence in areas with disease
prevalence
• Adolescents, females particularly
• Lower socio-economic status
• Use of drugs
• Exchange of sex for drugs or money
4
Gonorrhea Curriculum Epidemiology
Transmission
• Efficiently transmitted by:
– Male to female via semen
– Female to male urethra
– Rectal intercourse
– Fellatio (pharyngeal infection)
– Perinatal transmission (mother to infant)
• Gonorrhea associated with increased
transmission of and susceptibility to HIV
infection
5
Gonorrhea Curriculum
6
Gonorrhea Curriculum Pathogenesis
Microbiology
7
Gonorrhea Curriculum Pathogenesis
8
Gonorrhea Curriculum
9
Gonorrhea Curriculum Clinical Manifestations
10
Gonorrhea Curriculum Clinical Manifestations
Male Urethritis
• Symptoms
– Typically purulent or mucopurulent urethral
discharge
– Often accompanied by dysuria
– Discharge may be clear or cloudy
• Asymptomatic in 10% of cases
• Incubation period: usually 1-14 days for
symptomatic disease, but may be longer
11
Gonorrhea Curriculum Clinical Manifestations
Gonococcal Urethritis:
Purulent Discharge
12
Gonorrhea Curriculum Clinical Manifestations
Epididymitis
• Symptoms: unilateral testicular pain and
swelling
• Infrequent, but most common local
complication in males
• Usually associated with overt or
subclinical urethritis
13
Gonorrhea Curriculum Clinical Manifestations
14
Gonorrhea Curriculum Clinical Manifestations
15
Gonorrhea Curriculum Clinical Manifestations
Cervicitis
• Non-specific symptoms: abnormal vaginal
discharge, intermenstrual bleeding, dysuria,
lower abdominal pain, or dyspareunia
• Clinical findings: mucopurulent or purulent
cervical discharge, easily induced cervical
bleeding
• 50% of women with clinical cervicitis have
no symptoms
• Incubation period unclear, but symptoms
may occur within 10 days of infection
16
Gonorrhea Curriculum Clinical Manifestations
Gonococcal Cervicitis
17
Gonorrhea Curriculum Clinical Manifestations
Urethritis
• Symptoms: dysuria, however, most
women are asymptomatic
• 40%-60% of women with cervical
gonococcal infection may have urethral
infection
18
Gonorrhea Curriculum Clinical Manifestations
Complications in Women
• Accessory gland infection
– Bartholin’s glands
– Skene’s glands
• Pelvic Inflammatory Disease (PID)
• Fitz-Hugh-Curtis Syndrome
– Perihepatitis
19
Gonorrhea Curriculum Clinical Manifestations
Bartholin’s Abscess
20
Gonorrhea Curriculum Clinical Manifestations
• Anorectal infection
• Pharyngeal infection
• Conjunctivitis
• Disseminated gonococcal infection (DGI)
21
Gonorrhea Curriculum Clinical Manifestations
Gonococcal Ophthalmia
22
Gonorrhea Curriculum Clinical Manifestations
Disseminated Gonorrhea—
Skin Lesion
23
Gonorrhea Curriculum Clinical Manifestations
Gonorrhea Infection in
Children
• Perinatal: infections of the conjunctiva,
pharynx, respiratory tract
24
Gonorrhea Curriculum
25
Gonorrhea Curriculum Diagnosis
Diagnostic Methods
• Culture tests
• Non-culture tests
– Amplified tests (NAATs)
• Polymerase chain reaction (PCR) (Roche Amplicor)
• Transcription-mediated amplification (TMA) (Gen-Probe
Aptima)
• Strand displacement amplification (SDA) (Becton-Dickinson
BD ProbeTec ET)
– Non-amplified tests
• DNA probe (Gen-Probe PACE 2, Digene Hybrid Capture II)
– Gram stain
26
Gonorrhea Curriculum Diagnosis
Clinical Considerations
• In cases of suspected sexual abuse
– Legal standard is culture with multiple
tests to confirm the identity of Neisseria
gonorrhoeae
27
Gonorrhea Curriculum
Lesson V: Patient
Management
28
Gonorrhea Curriculum Management
29
Gonorrhea Curriculum Management
Co-treatment for
Chlamydia trachomatis
If chlamydial infection is not ruled out:
Azithromycin 1g Orally Once or
30
Gonorrhea Curriculum Management
Special Considerations:
Pregnancy
• Pregnant women should NOT be
treated with quinolones or tetracyclines
• Treat with alternate cephalosporin
• If cephalosporin is not tolerated, treat
with spectinomycin 2 g IM once
31
Gonorrhea Curriculum Management
Alternative Regimens
• Spectinomycin 2 g in a single IM dose
32
Gonorrhea Curriculum Management
Follow-Up
• A test of cure is not recommended if a
recommended regimen is administered.
• If symptoms persist, perform culture for
N. gonorrhoeae.
– Any gonococci isolated should be tested for
antimicrobial susceptibility.
33
Gonorrhea Curriculum
34
Gonorrhea Curriculum Prevention
Screening
• Pregnancy
– A test for N. gonorrhoeae should be
performed at the first prenatal visit for
women at risk or those living in an area in
which the prevalence of N. gonorrhoeae is
high.
– Repeat test during the 3rd trimester for those
at continued risk.
• Other populations can be screened
based on local disease prevalence and
35
Gonorrhea Curriculum Prevention
Partner Management
• Evaluate and treat all sex partners for N.
gonorrhoeae and C. trachomatis infections if
contact was within 60 days of symptoms or
diagnosis.
• If a patient’s last sexual intercourse was >60
days before onset of symptoms or diagnosis, the
patient’s most recent sex partner should be
treated.
• Avoid sexual intercourse until therapy is
completed and both partners no longer have
symptoms.
36